PBL - Innovation in Life Sciences
Early Stage Technology Investment, IP Management and Licensing
PBL develops innovative technologies from public and private sources worldwide - turning ideas into patented, scientifically validated and licensable technologies. PBL invests in building intellectual property protection, and develops technologies through proof-of-concept and prototype stage and licenses onwards to a wide variety of industry sectors. Our interests cover AgBiotech, Food / Nutrition, Microbiology, Biotechnology and related Life Science industries. We market our technologies internationally and have regular contact with a very wide range of industrial customers, licensees and development partners.
PBL was formed in 1994, and is now jointly and equally owned by the John Innes Centre, the Sainsbury Laboratory, and the BBSRC (Biotechnology and Biological Sciences Research Council).
Technology Investment Services for Public Sector Researchers
We offer various options for our services but most commonly work on a fully contingent, non-fee basis, instead taking a portion of future commercial revenues, shared with the original source of the technology. We commonly cover patent costs and can inject funds directly to carry out critical proof-of-concept or technology development work.
Please click here for more information.
IP Management and Patent Advisory Service for Bioscience Companies and Investors
PBL offers bioscience companies and investors a patent consultation and management service including: IP identification and assessment; IP strategy definition; IP portfolio management; IP due diligence.
Please click here for more information.
|
|
Latest News
April 2013
Beneforté Broccoli - New Research Published - Explained: Why Beneforte reliably delivers more glucoraphanin than standard broccoli
More info...
April 2013
Dicerna and PBL Sign Agreement for Baulcombe & Hamilton RNAi Patents
More info...
March 2013
PBL Awarded Further US Patent on Short RNAi Molecules: US 8,349,607
More info...
January 2013
Bioneer acquires Model Gut Contract Research business and is granted licence to the Dynamic Gastric Model
More info...
December 2012
Successes of PBL TEC Scheme: The Figures Speak for Themselves
More info...
November 2012
Growing Portfolio of Patents in Biocontrol Area
More info...
October 2012
PBL Awarded Further US Patent on Short RNAi Molecules: US 8,299,235
More info...
October 2012
Plant-Made Protein Platform: PBL and OBP Enter Licence for Animal Health Applications
More info...
October 2012
PBL in China: PBL to Promote New Technology from IGDB, Beijing
More info...
For all PBL news click here |
